PATHOGENETIC FACTORS OF ALZHEIMERS-DISEASE

被引:0
|
作者
BAUER, J
HULL, M
BERGER, M
机构
来源
关键词
ALZHEIMERS DISEASE; PATHOGENETIC FACTORS; SYNAPSE PATHOLOGY; NEUROFIBRILLARY CHANGES; AMYLOID DEPOSITS; CHOLINERGIC NEUROTRANSMISSION; APOLIPOPROTEIN E;
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The aim of this article is to review the pathogenetic factors of Alzheimer's disease. Primary correlates of Alzheimer's disease are a dysfunction of and a subsequent decrease in the number of cortical and hippocampal synapses: followed by neurofibrillary and neuritic changes of hippocampal and cortical neurons. While the synapse pathology has been shown to be an early event in Alzheimer's disease, a significant neurofibrillary and neuritic pathology appears to develop only during the course of the disease. Cortical amyloid deposits are an unspecific, age-related phenomenon that can also be found in the brains of the majority of nondemented elderly persons over the age of 65 years. Transgenic amyloid mice proved to be of only limited value as animal models of Alzheimer' disease. According to several studies, there is no correlation between the total number of cortical amyloid plaques and clinical parameters of dementia. However, such a correlation exists with respect to. the proportion of neuritic plaques, i.e., with respect to the degree of neuritic degeneration within plaques. In addition to these changes, an interleukin-6 associated inflammatory response has been found in the cortices of Alzheimer patients which is absent in the brains of nondemented elderly persons, and which therefore appears to be a specific element. The significance of changes in the cholinergic neurotransmission for Alzheimer's disease is discussed. Finally, the role of apolipoprotein E and other genetic risk factors is reviewed. In this context it is emphasized that in young persons apolipoprotein E4 is not a suitable early diagnostic marker for Alzheimer's disease.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 50 条
  • [31] ALZHEIMERS-DISEASE
    SMITH, CM
    SWASH, M
    STRESS MEDICINE, 1985, 1 (04): : 269 - 277
  • [32] ALZHEIMERS-DISEASE
    KRETSCHMAR, C
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1985, 127 (42): : 986 - 988
  • [33] ALZHEIMERS-DISEASE
    SISKIND, JG
    SOCIAL WORK, 1986, 31 (05) : 415 - 415
  • [34] ALZHEIMERS-DISEASE
    HYMAN, BT
    DAMASIO, H
    DAMASIO, AR
    VANHOESEN, GW
    ANNUAL REVIEW OF PUBLIC HEALTH, 1989, 10 : 115 - 140
  • [35] ALZHEIMERS-DISEASE
    CORKIN, S
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1989, 39-2 (8A): : 957 - 960
  • [36] ALZHEIMERS-DISEASE
    GABRIEL, YH
    WISCONSIN MEDICAL JOURNAL, 1980, 79 (05): : 9 - 9
  • [37] ALZHEIMERS-DISEASE
    RICH, V
    CHEMISTRY IN BRITAIN, 1989, 25 (10) : 992 - 992
  • [38] ALZHEIMERS-DISEASE
    HUTTON, JT
    TEXAS MEDICINE, 1987, 83 (01) : 6 - 7
  • [39] ALZHEIMERS-DISEASE
    HARDY, JA
    DAVIES, DC
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1988, 39 (05): : 372 - &
  • [40] ALZHEIMERS-DISEASE
    不详
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1984, 35 (11): : 1152 - 1153